New drug aims to restore skin color in vitiligo patients
NCT ID NCT06905873
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a new drug called FB102 in 64 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Half will get the drug and half a placebo, both given by IV. The main goal is to check safety and see if the drug helps bring back skin color on the face.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FB102 (a drug given by IV infusion)
- What this could lead to
- If it works, this could point toward a new treatment to restore skin color in people with vitiligo.
- What could go wrong
- This is a very early Phase 1 trial with only 64 people, so it is primarily checking safety. It may not show clear benefit, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornerstone Dermatology
RECRUITINGCoorparoo, Queensland, 4151, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Momentum Pukehoke
RECRUITINGAuckland, Auckland, 2120, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novatrials
RECRUITINGKotara, New South Wales, 2289, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Optimal Clinical Trials Central
RECRUITINGAuckland, Auckland, 1010, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Optimal Clinical Trials North
RECRUITINGAuckland, Auckland, 0632, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skin & Cancer Foundation Australia - The Skin Hospital
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?
- New shot plus light therapy aims to restore skin color in vitiligo